ストックスクリーナーアプリを入手
46.43
11.16%
-5.83
プレマーケット:
46.78
0.35
+0.75%
前日終値:
$52.26
開ける：
$50.82
24時間の取引高:
8.80M
Relative Volume:
1.52
時価総額：
$8.34B
収益：
$1.36B
当期純損益:
$-302.91M
株価収益率:
-27.02
EPS:
-1.7182
ネットキャッシュフロー:
$-219.93M
1週間 パフォーマンス:
-8.00%
1か月 パフォーマンス:
-14.13%
6か月 パフォーマンス:
-39.43%
1年 パフォーマンス:
-20.85%
1日の値動き範囲:
$45.84
$52.23
1週間の範囲:
$45.84
$54.75
52週間の値動き範囲:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Compare TEM vs VEEV, BTSG, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
46.43 | 9.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
172.61 | 29.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
57.40 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
88.67 | 7.19B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
63.62 | 4.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Underperform |
| 2026-04-13 | アップグレード | TD Cowen | Hold → Buy |
| 2026-02-19 | 開始されました | Mizuho | Outperform |
| 2026-02-17 | 開始されました | Robert W. Baird | Outperform |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-21 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-21 | 開始されました | BTIG Research | Buy |
| 2025-02-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 再開されました | TD Cowen | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-12-09 | 開始されました | Guggenheim | Buy |
| 2024-11-11 | ダウングレード | Stifel | Buy → Hold |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-12 | 開始されました | Piper Sandler | Neutral |
| 2024-07-09 | 開始されました | BofA Securities | Buy |
| 2024-07-09 | 開始されました | JP Morgan | Overweight |
| 2024-07-09 | 開始されました | Longbow | Buy |
| 2024-07-09 | 開始されました | Loop Capital | Buy |
| 2024-07-09 | 開始されました | Morgan Stanley | Overweight |
| 2024-07-09 | 開始されました | Needham | Buy |
| 2024-07-09 | 開始されました | Stifel | Buy |
| 2024-07-09 | 開始されました | TD Cowen | Buy |
| 2024-07-09 | 開始されました | William Blair | Outperform |
すべてを表示
Tempus Ai Inc (TEM) 最新ニュース
Tempus AI to present at Goldman Sachs healthcare conference - scanx.trade
Geode Capital Management LLC Boosts Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Lelezard
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth Narrative - Yahoo Finance
TD Cowen raises Tempus AI stock price target on genomics strength - Investing.com
ARK's Stock Pick: $LLY & $TEM Hold Strong as AI Growth Stocks Plunge — Defensive Biotech Shines - Moomoo
TEM Technical Analysis & Stock Price Forecast - Intellectia AI
AI that predicts clinical outcomes? Tempus AI in focus after ASCO data reveal - MSN
Tempus (TEM) Gets Double-Digit Boost from New Partnerships - Insider Monkey
Tempus AI (NASDAQ:TEM) Trading Up 9.3%Time to Buy? - MarketBeat
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Tempus AI Stock Pops As FDA Win Fuels Growth Story - StocksToTrade
Why Tempus AI Stock Is Surging On Thursday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Australia
Tempus AI (TEM) Jumps As FDA Win Fuels Bullish Momentum - timothysykes.com
Why Is Tempus (TEM) Down 11.2% Since Last Earnings Report? - Yahoo Finance
$Tempus AI (TEM.US)$ thanks for the ride [Drool] - Moomoo
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI launches digital pathology open-source consortium - Investing.com UK
Tempus AI (TEM) director Epstein sells 250 shares in pre-planned trade - Stock Titan
Tempus AI Stock (TEM) Opinions on Analyst Coverage Initiation - Quiver Quantitative
Tempus AI launches digital pathology open-source consortium By Investing.com - Investing.com Nigeria
Tempus AI Launches Open-Source Digital Pathology Consortium With Yale New Haven Health - geneonline.com
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members - Yahoo Finance
Canaccord Genuity Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM) - The Globe and Mail
$Tempus AI (TEM.US)$ someday… you will be wonderful again… - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at Wolfe Research - MarketBeat
Canaccord reiterates Tempus AI stock rating citing growth potential By Investing.com - Investing.com South Africa
Canaccord reiterates Tempus AI stock rating citing growth potential - Investing.com
Tempus AI, Inc. $TEM Shares Bought by Lingotto Investment Management LLP - MarketBeat
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY) - The Globe and Mail
AXQ Capital LP Buys Shares of 26,002 Tempus AI, Inc. $TEM - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Wolfe Research initiates Tempus AI stock coverage with Peerperform By Investing.com - Investing.com South Africa
Wolfe Research initiates Tempus AI stock coverage with Peerperform - Investing.com UK
Tempus AI (TEM) Launches Next-Gen Sequencing Test for Oncology - GuruFocus
Stifel Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $60 - Moomoo
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Tempus xH test finds 40% more genomic findings than standard care - Stock Titan
Needham Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $75 - Moomoo
Tempus AI's (TEM) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Tempus AI: Buy Rating Reiterated as Analyst Maintains $75 Price Target on Durable Growth and Improving Financial Profile - TipRanks
William Blair Maintains Tempus AI(TEM.US) With Hold Rating - Moomoo
Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development - Moomoo
Tempus AI, Inc. (TEM) Stock Analysis: Exploring a 33.15% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development - BioSpace
Tempus Ai Inc (TEM) 財務データ
収益
当期純利益
現金流量
EPS
Tempus Ai Inc (TEM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LEFKOFSKY ERIC P | CEO and Chairman |
May 27 '26 |
Sale |
46.70 |
166,250 |
7,763,312 |
8,808,533 |
3.07%
7.34%
大文字化:
|
ボリューム (24 時間):